Pharmacokinetic and pharmacodynamic modeling of pegylated-interferon alfa

被引：0
|
作者：
Dimova, Rositsa B.
Talal, Andrew H. [1 ]
机构：
[1] Weill Cornell Med Coll, Ctr Study Hepatitis C, New York, NY 10065 USA
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 53卷 / 03期
关键词：
HEPATITIS-C VIRUS; INFECTED PATIENTS; HCV; RIBAVIRIN; KINETICS; HIV; RESPONSES; EFFICACY; DYNAMICS; THERAPY;
D O I：
10.1016/j.jhep.2010.04.014
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：418 / 420
页数：3
相关论文
共 50 条
  • [1] A European single centre experience of management of hepatitis C virus genotype 4 infection with pegylated-interferon and ribavirin
    Selvapatt, Nowlan
    Habibi, Maximillian S.
    Brown, Ashley
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (10) : 1716 - 1721
  • [2] A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α
    Mangioni, Davide
    Soria, Alessandro
    Brighina, Laura
    Bandera, Alessandra
    Ferrarese, Carlo
    Gori, Andrea
    BMC PHARMACOLOGY & TOXICOLOGY, 2014, 15
  • [3] Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma
    Daud, A. I.
    Xu, C.
    Hwu, W. -J.
    Urbas, P.
    Andrews, S.
    Papadopoulos, N. E.
    Floren, L. C.
    Yver, A.
    DeConti, R. C.
    Sondak, V. K.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (03) : 657 - 666
  • [4] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Irit Rosen
    Michal Kori
    Orly Eshach Adiv
    Baruch Yerushalmi
    Nataly Zion
    Ron Shaoul
    World Journal of Gastroenterology, 2013, (07) : 1098 - 1103
  • [5] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Rosen, Irit
    Kori, Michal
    Adiv, Orly Eshach
    Yerushalmi, Baruch
    Zion, Nataly
    Shaoul, Ron
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (07) : 1098 - 1103
  • [6] Onset of Type 1 Diabetes Mellitus During Pegylated-interferon Alfa and Ribavirin Therapy for Chronic Hepatitis C Virus Infection
    Ranganathan, Raghini
    Janarthanan, Krishnaveni
    Rajasekaran, Senthilkumar
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2012, 2 (01) : 86 - 87
  • [7] Bayesian Approach for Population Pharmacokinetic Modeling of Pegylated Interferon α-2a in Hepatitis C Patients
    Saleh, Mohammad I.
    CLINICAL PHARMACOKINETICS, 2017, 56 (11) : 1369 - 1379
  • [8] Pegylated Interferon Alfa-2a Monotherapy for Hemodialysis Patients with Acute Hepatitis C
    Liu, Chen-Hua
    Liang, Cheng-Chao
    Liu, Chun-Jen
    Lin, Jou-Wei
    Chen, Shih-I
    Hung, Peir-Haur
    Tsai, Hung-Bin
    Lai, Ming-Yang
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (05) : 541 - 549
  • [9] IMPACT OF THE PEGYLATED-INTERFERON AND RIBAVIRIN THERAPY ON THE TREATMENT-RELATED MORTALITY OF PATIENTS WITH CIRRHOSIS DUE TO HEPATITIS C VIRUS
    Nomura Dresch, Kelly Fernanda
    de Mattos, Angelo Alves
    Tovo, Cristiane Valle
    de Onofrio, Fernanda Quadros
    Casagrande, Leandro
    Feltrin, Alberi Adolfo
    de Barros, Iago Christofoli
    Lerias de Almeida, Paulo Roberto
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2016, 58
  • [10] Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas
    Mazzaro, Cesare
    De Re, Valli
    Spina, Michele
    Dal Maso, Luigino
    Festini, Gianluca
    Comar, Consuelo
    Tirelli, Umberto
    Pozzato, Gabriele
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (02) : 255 - 257
12345